ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,215, issued on Dec. 9, was assigned to JUMBO DRUG BANK Co. LTD. (Sichuan, China).

"Pyrrolotriazine compounds acting as MNK inhibitor" was invented by Lingyun Wu (Shanghai), Xiawei Wei (Sichuan, China), Peng Yang (Shanghai), Lele Zhao (Shanghai), Chen Zhang (Shanghai), Ning Jiang (Sichuan, China), Wei Zheng (Sichuan, China), Jian Li (Shanghai) and Shuhui Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are pyrrolotriazine compounds which act as a mitogen-activated protein kinase interacting kinase (MNK) inhibitor, and the use thereof in the preparation of a mitogen-activated protein kinase interacting kinase inhibitor drug. Spec...